Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty

Recruiting now · Phase 1

Conditions studied: Mild to Moderate Corneal Endothelial Decompensation, Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Post-surgical Corneal Decompensation (Irreversible)

In brief

Assessment of safety and efficacy of tissue-engineered corneal endothelial graft material generated using cultured human corneal endothelial cells for tissue-engineered endothelial keratoplasty (TE-EK).

Key facts

Study ID
NCT04319848
Run by
Singapore Eye Research Institute
People needed
30
Starts
2017-12-01
Expected to finish
2028-06-01
Last updated by the study team
2025-09-12

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.